Who
Benjamin J. Hindson
Director and Officer
Company insider
Files Form 4 as: Director and Officer and 10% owner, 10x Genomics.
In numbers
- Trades disclosed
- 284
- Buys
- 0
- Sells
- 49
- Bought
- $0
- Sold
- $127.2M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 16 Sep 2019
- Last trade
- 24 Aug 2026
- Last filed
- 26 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Aug 2026filed 26 Aug 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $871K13,818 at $63.02 | filing |
| 24 Aug 2026filed 26 Aug 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $871K13,818 at $63.02 | filing |
| 22 May 2026filed 27 May 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $283K11,595 at $24.44 | filing |
| 22 May 2026filed 27 May 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $283K11,595 at $24.44 | filing |
| 26 Feb 2026filed 2 Mar 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Code A | —88,816 at $0.00 | filing |
| 26 Feb 2026filed 2 Mar 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Code A | —88,816 at $0.00 | filing |
| 23 Feb 2026filed 25 Feb 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $145K7,826 at $18.58 | filing |
| 23 Feb 2026filed 25 Feb 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $145K7,826 at $18.58 | filing |
| 24 Nov 2025filed 25 Nov 2025 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $157K8,283 at $19.00 | filing |
| 22 Aug 2025filed 26 Aug 2025 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $103K7,486 at $13.79 | filing |
| 22 May 2025filed 27 May 2025 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $62K7,485 at $8.30 | filing |
| 17 Mar 2025filed 19 Mar 2025 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Code A | —120,535 at $0.00 | filing |
| 24 Feb 2025filed 26 Feb 2025 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $51K4,573 at $11.07 | filing |
| 22 Nov 2024filed 25 Nov 2024 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $79K5,807 at $13.69 | filing |
| 22 Aug 2024filed 26 Aug 2024 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $98K4,351 at $22.53 | filing |
| 22 May 2024filed 23 May 2024 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $99K4,087 at $24.30 | filing |
| 21 Mar 2024filed 25 Mar 2024 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Code A | —71,083 at $0.00 | filing |
| 22 Feb 2024filed 26 Feb 2024 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $121K2,613 at $46.34 | filing |
| 28 Dec 2023filed 29 Dec 2023 | TXG 10x Genomicsoption or derivative · Life-science tools | SEC FORM 4 Code M | —8,334 at $0.00 | filing |
| 28 Dec 2023filed 29 Dec 2023 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Code M | $96K8,334 at $11.48 | filing |
News
10x Genomics (NASDAQ:TXG) Cut to "Equal Weight" at StephensTXG · dailypolitical.com · 26 Oct 20267,724 Shares in 10x Genomics $TXG Bought by QP Wealth Management LLCTXG · dailypolitical.com · 21 Oct 2026
0 headlines in the last 90 days name Benjamin J. Hindson; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.